BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Finch Therapeutics Expands Senior Leadership Team with Appointments of Dr. Ulrich Thienel as Chief Medical Officer and Gregory Perry as Chief Financial Officer

  Dr. Thienel will lead the clinical development of Finch’s Full-Spectrum Microbiota™ and Rationally-Selected Microbiota™ platforms, while Mr. Perry will provide strategic financial and operational leadership at Finch.

  June 12, 2018

   · 

  4 min read
• Business

  CytoSorbents Officially Opens New U.S. CytoSorb Manufacturing Facility

  New facility quadruples production capacity and is expected to accelerate margin expansion and drive operating profitability

  June 12, 2018

   · 

  4 min read
• Pharm Country

  Pfizer Announces Extension of Zithromax® Antibiotic Donation Program through 2025 to Help Eliminate World’s Leading Infectious Cause of Blindness

  Pfizer Inc. announced today it will extend its donation of the antibiotic Zithromax® (azithromycin) to the International Trachoma Initiative through 2025.

  June 12, 2018

   · 

  8 min read
• Drug Development

  Rigel To Present Phase 2 Results for Fostamatinib in Autoimmune Hemolytic Anemia at EHA

  Rigel Pharmaceuticals, Inc. announced that it will be presenting an oral presentation on the Phase 2 Stage 1 interim results for fostamatinib in patients with warm antibody hemolytic anemia (AIHA) at the 23rd Congress of the European Hematology Association (EHA)

  June 12, 2018

   · 

  4 min read
• ProMIS Neurosciences Initiates Manufacturing of PMN310, its Lead Therapeutic Antibody for Treatment of Alzheimer’s Disease

  ProMIS Neurosciences, Inc. announced the initiation of producer cell line development for PMN310

  June 12, 2018

   · 

  4 min read
• Genetown

  Enanta Pharmaceuticals Recognizes the 1st International NASH Day

  Enanta Pharmaceuticals, Inc. is proud to support the 1st International NASH Day taking place today.

  June 12, 2018

   · 

  3 min read
• FDA

  Fujirebio Diagnostics Announces FDA Clearance of Lumipulse G B•R•A•H•M•S PCT Assay

  Testing for Change in PCT Levels Assists with Antibiotic Stewardship and Risk Assessment Of Lower Respiratory Tract Infections and Sepsis

  June 12, 2018

   · 

  3 min read
• Business

  Marken Moves Chicago Operations To New Full Service Location

  Logistics Hub Relocated and Expanded to Serve Local Clinical Trial Clients

  June 12, 2018

   · 

  2 min read
• Drug Development

  Update on Phase 3 Clinical Trials of Lanabecestat for Alzheimer’s Disease

  Independent data monitoring committee advises lanabecestat is unlikely to meet primary endpoints, leading to decision to discontinue these trials

  June 12, 2018

   · 

  6 min read
• Targovax Hosts Conference Call 12 June 2018

  Targovax ASA hosts a conference call to give an update to its clinical development strategy.

  June 12, 2018

   · 

  2 min read